Gujchem Distilleries Share Price Today

ZR2 Bioenergy Q1 Results: Net profit up 29% YoY to ₹22.01 lakh

ZR2 Bioenergy Limited reported a 29% YoY increase in Q1FY27 standalone net profit to ₹22.01 lakh, driven by other income as operational revenue remains nil. The firm is transitioning into bioenergy via an ethanol plant acquisition and agri-commodity trading. Consolidated profits also rose 19% YoY to ₹22.01 lakh. Auditors issued an unqualified review opinion.

ZR2 Bioenergy closes trading window from July 1 until Q1FY27 results

ZR2 Bioenergy Ltd closed its trading window from July 1, 2026, until 48 hours after the Q1FY27 results declaration, complying with SEBI insider trading regulations. The Board meeting date for the quarter ended June 30, 2026, is pending announcement.

ZR2 Bioenergy board to consider FY26 results on May 29

ZR2 Bioenergy Limited has scheduled a board meeting on May 29, 2026, to consider and approve the audited financial results for the quarter and financial year ended March 31, 2026. The meeting, held under Regulation 29 of the LODR Regulations, will cover standalone and consolidated results. The trading window has been closed since April 1, 2026, and will reopen 48 hours after the results declaration.

ZR2 Bioenergy's Q4FY26 Monitoring Agency Report Flags Deviation in Deployment of Unutilized Proceeds

ZR2 Bioenergy Limited has filed its Q4FY26 Monitoring Agency Report, prepared by Crisil Ratings Limited, disclosing that Rs 18.50 crore of unutilized Preferential Issue proceeds remains deployed in a short-term deposit with Sukhmehar Finance Private Limited, a non-deposit-taking NBFC — a deviation from standard industry practice. The total revised issue proceeds stand at Rs 122.40 crore, reduced from the original Rs 248.77 crore following forfeiture of warrant subscription amounts. Cumulative utilization as at March 31, 2026, stands at Rs 103.90 crore, with no fresh utilization reported during the quarter. The Board has revised the estimated date for utilization of GCP proceeds to FY 2027.

ZR2 Bioenergy Limited Forfeits Rs. 42.12 Crores Following Non-Exercise of Warrant Conversion Options

ZR2 Bioenergy Limited has forfeited Rs. 42,12,32,500 from seven warrant holders who failed to exercise conversion options within the 18-month deadline ending February 13, 2026. The warrants were originally allotted on May 10, 2024, at Rs. 65 each to strategic investors and proposed promoters. The forfeiture affects 2,59,22,000 warrants and has been disclosed under SEBI regulations.

ZR2 Bioenergy Limited Allots 1,23,50,000 Equity Shares Following CCD Conversion Worth Rs. 80.28 Crores

ZR2 Bioenergy Limited has allotted 1,23,50,000 equity shares to ZR2 Group Holdings Limited following CCD conversion at Rs. 65 per share, raising Rs. 80.28 crores. This transaction increased ZR2 Group Holdings' stake from 61% to 91.26%. The new shares carry equal rights with existing shares, and the company will seek BSE listing approval.